Condition

Cerebrovascular Disease

ClinicalTrials.gov condition label

Clinical trials19
Recruiting2
Common interventions19
Lead sponsors shown15

Clinical trials

19 shown
NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)NCT07820800 · 2026-09-01
RECRUITING
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAGNCT06567795 · 2024-03-14
RECRUITING
REnal Denervation After Stroke (REDs) Study - A Randomized Clinical Trial of Renal Denervation in the Subacute Phase of StrokeNCT07114757 · 2025-09-25
NOT_YET_RECRUITING
Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and ParagangliomasNCT07316075 · 2024-02-05
ENROLLING_BY_INVITATION
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)NCT06959784 · 2024-01-01
ENROLLING_BY_INVITATION
The North Kynouria ProjectNCT06115213 · 2022-11-01
UNKNOWN
Diabetes Complications and the Risk of Cardiovascular and Cerebrovascular DiseasesNCT04983277 · 2021-07-01
NOT_YET_RECRUITING
Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF TrialNCT04696120 · 2021-03-02
UNKNOWN
Integrated Primary Care for Diabetes and Cardiovascular DiseaseNCT02795910 · 2017-04-01
UNKNOWN
Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality ImagingNCT02440646 · 2015-05-01
TERMINATED
"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic PopulationNCT02248311 · 2014-09-01
UNKNOWN
Co-LEsions in Alzheimer Disease and Related DisordersNCT02052947 · 2014-01-01
UNKNOWN
Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular DiseaseNCT01924312 · 2013-05-01
COMPLETED
Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older PeopleNCT01650402 · 2011-12-01
COMPLETED
Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS)NCT01323322 · 2009-07-01
ACTIVE_NOT_RECRUITING
Pulmonary Hypertension, Hypoxia and Sickle Cell DiseaseNCT00495638 · 2007-06-28
COMPLETED
Association of Long-term Conditions With Survival Following Heart Attack in England and WalesNCT03037255 · 2003-01-01
COMPLETED
Evaluation of Programs of Coordinated Care and Disease ManagementNCT00627029 · 2000-09-01
UNKNOWN
Registry of Cardiovascular Disease PatientsNCT01759225 · 1998-01-01
ENROLLING_BY_INVITATION

Common interventions

Anti-hypertensive therapy to SBP 130 mm HgOTHER1Anti-hypertensive therapy to SBP 145 mm HgOTHER1ApixabanDRUG1Care CoordinationBEHAVIORAL1Coronary computed tomography angiographyRADIATION1Digital health interventionsBEHAVIORAL1Heart Health InterventionBEHAVIORAL1HemotagDEVICE1long term conditionsOTHER1MetforminDRUG1no interventionOTHER1No outreach education trainingBEHAVIORAL1Outreach education trainingBEHAVIORAL1Patient counsellingBEHAVIORAL1PlaceboDRUG1Quantitative coronary angiography, intravascular imaging with percutaneous interventionRADIATION1Renal denervation after strokePROCEDURE1semaglutideDRUG1SPECT-DaTscanRADIATION1

Leading sponsors

Aventusoft, LLC.1Central Clinical Hospital of the Russian Academy of Sciences1Centro per la Lotta Contro l'Infarto - Fondazione Onlus1China-Japan Friendship Hospital1Gregory Jicha, 323-55501Hospices Civils de Lyon1Hospital Universitari Vall d'Hebron Research Institute1Korea University Guro Hospital1Laikο General Hospital, Athens1Maccabi Healthcare Services, Israel1Marlous Hall1Mathematica Policy Research, Inc.1National Heart, Lung, and Blood Institute (NHLBI)1National Institute on Aging (NIA)1Second Affiliated Hospital, Zhejiang University, School of Medicine1

Trial status mix

UNKNOWN6
COMPLETED4
ENROLLING_BY_INVITATION3
NOT_YET_RECRUITING2
RECRUITING2
ACTIVE_NOT_RECRUITING1
TERMINATED1

Phase mix

NA8
PHASE21
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.